Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 31.8 | 19.5 | 5.4 |
| Revenue growth | 63.0% | 261.4% | |
| Cost of goods sold | 13.8 | 11.7 | 8.9 |
| Gross profit | 18.0 | 7.8 | -3.6 |
| Gross margin | 56.5% | 40.0% | -65.8% |
| Selling, general and administrative | 52.4 | 38.4 | 18.7 |
| Research and development | 15.5 | 13.3 | 12.2 |
| EBIT | -50.0 | -43.9 | -34.4 |
| EBIT margin | -157.2% | -225.0% | -637.8% |
| Pre-tax income | -57.1 | -50.1 | -43.1 |
| Income taxes | 0.3 | 0.2 | 0.2 |
| Net income | -57.4 | -50.3 | -43.3 |
| Net margin | -180.4% | -257.9% | -802.4% |
| |
| Diluted EPS | ($3.95) | ($87.42) | ($101.97) |
| Shares outstanding (diluted) | 14.5 | 0.6 | 0.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|